ATE292461T1 - Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen - Google Patents

Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen

Info

Publication number
ATE292461T1
ATE292461T1 AT01958434T AT01958434T ATE292461T1 AT E292461 T1 ATE292461 T1 AT E292461T1 AT 01958434 T AT01958434 T AT 01958434T AT 01958434 T AT01958434 T AT 01958434T AT E292461 T1 ATE292461 T1 AT E292461T1
Authority
AT
Austria
Prior art keywords
ibuprofen
capsule
preparations
agent
filling
Prior art date
Application number
AT01958434T
Other languages
English (en)
Inventor
Soichiro Kato
Katsuyuki Tsumori
Yasuo Shinoda
Toshio Inagi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE292461T1 publication Critical patent/ATE292461T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01958434T 2000-08-25 2001-08-23 Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen ATE292461T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000255827 2000-08-25
PCT/JP2001/007223 WO2002015900A1 (en) 2000-08-25 2001-08-23 Ibuprofen solutions for capsule-filling and capsule prepartions

Publications (1)

Publication Number Publication Date
ATE292461T1 true ATE292461T1 (de) 2005-04-15

Family

ID=18744550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958434T ATE292461T1 (de) 2000-08-25 2001-08-23 Ibuprofen-lösungen als kapselfüllung und kapsel- zubereitungen

Country Status (14)

Country Link
US (1) US20030187070A1 (de)
EP (1) EP1321140B1 (de)
JP (1) JP3553562B2 (de)
KR (1) KR100762115B1 (de)
CN (1) CN1215837C (de)
AT (1) ATE292461T1 (de)
AU (1) AU2001280124A1 (de)
CA (1) CA2419147C (de)
DE (1) DE60109945T2 (de)
EA (1) EA005494B1 (de)
ES (1) ES2240492T3 (de)
PT (1) PT1321140E (de)
TW (1) TWI285115B (de)
WO (1) WO2002015900A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005206084A1 (en) * 2004-01-09 2005-08-04 Wyeth Microemulsions for pharmaceutical compositions
JP4710240B2 (ja) * 2004-03-31 2011-06-29 ゼリア新薬工業株式会社 医薬組成物
JP2005289905A (ja) * 2004-03-31 2005-10-20 Zeria Pharmaceut Co Ltd 医薬組成物
US20060088590A1 (en) * 2004-10-22 2006-04-27 Banner Pharmacaps, Inc. Non-blooming gelatin and non-gelatin formulations
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa, Inc. formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
US20070224261A1 (en) * 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
KR20130055595A (ko) 2010-04-15 2013-05-28 크로모셀 코포레이션 쓴맛을 감소시키거나 제거하기 위한 화합물, 조성물 및 방법
HK1201177A1 (en) 2011-10-20 2015-08-28 Chromocell Corporation Compounds, compositions, and methods for reducing or eliminating bitter taste
JP2017526638A (ja) * 2014-06-30 2017-09-14 ミトコンドリアル サブストレート インベンション リミテッドＭｉｔｏｃｈｏｎｄｒｉａｌ Ｓｕｂｓｔｒａｔｅ Ｉｎｖｅｎｔｉｏｎ Ｌｉｍｉｔｅｄ 認知機能向上のための栄養素溶液
WO2016084099A1 (en) * 2014-11-25 2016-06-02 Biological E Limited Soft gelatin capsule composition of anti-tussive agents
EP3863603A1 (de) 2018-10-08 2021-08-18 Chanelle Pharmaceuticals Manufacturing Ltd. Weichgelkapselformulierung, verfahren zu ihrer herstellung und ihre verwendung
JP7792195B2 (ja) * 2019-12-24 2025-12-25 アリナミン製薬株式会社 医薬組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
UA34430C2 (uk) * 1991-05-13 2001-03-15 Дзе Бутс Компані Плс S(-)-2-(4-ізобутилфеніл)пропіонат натрію дигідрат, придатний для лікування запалення, болю і гіпертермії, фармацевтична композиція на його основі та спосіб одержання s(-)-2-(4-ізобутилфеніл)пропіонату натрію
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
FI955144L (fi) * 1993-04-30 1995-10-31 Procter & Gamble Päällystetyt farmaseuttiset koostumukset
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
JPH08333246A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
AU3444297A (en) * 1996-07-12 1998-02-09 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
US5914129A (en) * 1996-07-23 1999-06-22 Mauskop; Alexander Analgesic composition for treatment of migraine headaches
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
ES2282134T3 (es) * 1999-09-11 2007-10-16 THE PROCTER & GAMBLE COMPANY Copolimeros de polioxialquileno que contienen vehiculos liquidos fluidos.

Also Published As

Publication number Publication date
WO2002015900A1 (en) 2002-02-28
CN1215837C (zh) 2005-08-24
CN1471389A (zh) 2004-01-28
EP1321140A4 (de) 2004-01-21
EP1321140A1 (de) 2003-06-25
US20030187070A1 (en) 2003-10-02
TWI285115B (en) 2007-08-11
EA005494B1 (ru) 2005-02-24
ES2240492T3 (es) 2005-10-16
AU2001280124A1 (en) 2002-03-04
CA2419147C (en) 2008-10-07
PT1321140E (pt) 2005-06-30
KR20030068535A (ko) 2003-08-21
EP1321140B1 (de) 2005-04-06
DE60109945T2 (de) 2006-04-27
KR100762115B1 (ko) 2007-10-04
JP3553562B2 (ja) 2004-08-11
DE60109945D1 (de) 2005-05-12
JPWO2002015900A1 (ja) 2004-06-10
EA200300292A1 (ru) 2003-10-30
CA2419147A1 (en) 2003-02-10

Similar Documents

Publication Publication Date Title
DE60109945D1 (de) IBUPROFEN-LöSUNGEN ALS KAPSELFüLLUNG UND KAPSEL-ZUBEREITUNGEN
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
PT1267832E (pt) Sistema auto-emulsionante de libertacao de farmaco
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
ATE187067T1 (de) Hochdosierte arzneizusammensetzungen
DE60123384D1 (de) Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
EP1365749A4 (de) Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
NO20011217D0 (no) Doseringsform omfattende væskeformulering
MX9801727A (es) Composicion farmaceutica para administracion oral.
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
DE69736140D1 (de) Pharmazeutische injizierbare Lösungen, die Paracetamol und Kombinationen aus Paracetamol mit anderen Aktivsubstanzen enthalten
AR027554A1 (es) Nuevo sistema de adminstracion de farmacos autoemulsionante
IT1307852B1 (it) Un dispositivo per la somministrazione per via transcutanea dimolecole contenute in un prodotto veicolante relativamente viscoso,
EP1221926A4 (de) Pharmazeutische zusammensetzungen mit schlecht löslichen arzneimittelwirkstoffen
AR036304A1 (es) Sistema nuevo de liberacion de droga autoemulsionable
HN2003000115A (es) Formulacion farmaceutica que comprende melatonina
ES2051658T1 (es) Comprimido efervescente de facil administracion.
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
JPS5762220A (en) Embrocation for external use
UY26503A1 (es) " forma de dosificación de fármacos accionada por un hidrogel"
AR027555A1 (es) Nuevo sistema de administracion de farmacos emulsionante
WO2002024173A3 (de) Orale zubereitungsformen von extrakten aus boswellia
TH51181A (th) ตำรับสูตรยาใช้ทางปากสำหรับสารประกอบต้านเนื้องอก
ECSP024290A (es) Composiciones farmacéuticas y uso de las mismas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties